Alrushaid, S.; Sayre, C.L.; Yáñez, J.A.; Forrest, M.L.; Senadheera, S.N.; Burczynski, F.J.; Löbenberg, R.; Davies, N.M.
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics 2017, 9, 35.
https://doi.org/10.3390/pharmaceutics9030035
AMA Style
Alrushaid S, Sayre CL, Yáñez JA, Forrest ML, Senadheera SN, Burczynski FJ, Löbenberg R, Davies NM.
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics. 2017; 9(3):35.
https://doi.org/10.3390/pharmaceutics9030035
Chicago/Turabian Style
Alrushaid, Samaa, Casey L. Sayre, Jaime A. Yáñez, M. Laird Forrest, Sanjeewa N. Senadheera, Frank J. Burczynski, Raimar Löbenberg, and Neal M. Davies.
2017. "Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative" Pharmaceutics 9, no. 3: 35.
https://doi.org/10.3390/pharmaceutics9030035
APA Style
Alrushaid, S., Sayre, C. L., Yáñez, J. A., Forrest, M. L., Senadheera, S. N., Burczynski, F. J., Löbenberg, R., & Davies, N. M.
(2017). Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics, 9(3), 35.
https://doi.org/10.3390/pharmaceutics9030035